https://theprint.in/health/new-drug-for-acute-leukaemia-leads-53-to-complete-or-partial-remission-in-us-trials/1445557/
Revumenib found to be promising in 2 studies by US researchers published in 'Nature' Wednesday. Leukaemia accounted for nearly 4% of global cancer deaths in 2020.
Create an account or login to join the discussion